Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Inflammatory Bowel Diseases

  Free Subscription


26.01.2026

1 AJR Am J Roentgenol
3 Am J Gastroenterol
1 BMC Gastroenterol
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
2 Gut
2 Inflamm Bowel Dis
5 J Clin Gastroenterol
3 J Crohns Colitis
2 Lancet Gastroenterol Hepatol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. SCHARITZER M
    Redefining Crohn Disease Phenotypes: The Rationale for Recognizing Probable Strictures.
    AJR Am J Roentgenol. 2026 Jan 21. doi: 10.2214/AJR.26.34522.
    PubMed        


    Am J Gastroenterol

  2. BEDELL A, McDermott AR, Karpin JE, Rodriguez TG, et al
    Ethical and Practical Considerations for Mental Health Screening in Adult Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2026 Jan 22. doi: 10.14309/ajg.0000000000003927.
    PubMed         Abstract available

  3. TARIQ R, Sethi A, Arunachalam S, Pardi DS, et al
    Machine Learning Model Predicts Recurrent Clostridioides difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD).
    Am J Gastroenterol. 2026 Jan 21. doi: 10.14309/ajg.0000000000003922.
    PubMed         Abstract available


  4. Correction to: Clinical Evolution, Complications, and Need for Advanced Therapy in Patients With Ulcerative Colitis (Abstract S2018); Pioneering Minimally Invasive Management of Pancreatic Neuroendocrine Tumor: First EUS-RFA Case in Colombia (Abstract
    Am J Gastroenterol. 2026 Jan 22. doi: 10.14309/ajg.0000000000003893.
    PubMed        


    BMC Gastroenterol

  5. ANDO K, Kashima S, Sakatani A, Konishi H, et al
    Intestinal transcriptomic analysis and prediction of biomarkers associated with mucosal healing following vedolizumab treatment in ulcerative colitis using machine learning.
    BMC Gastroenterol. 2026 Jan 17. doi: 10.1186/s12876-025-04599.
    PubMed        


    Dig Dis Sci

  6. TOLU T, Kani HT
    Beyond Adiposity: Lean Mass Phenotyping and Adipokine Interpretation in Pediatric Crohn's Disease.
    Dig Dis Sci. 2026 Jan 22. doi: 10.1007/s10620-026-09681.
    PubMed        


    Eur J Gastroenterol Hepatol

  7. BUCHNER AM, Kohen R, Sonnenberg A
    Epstein-Barr virus infection increases the risk for inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2025 Nov 26. doi: 10.1097/MEG.0000000000003109.
    PubMed         Abstract available


    Gut

  8. PARIGI TL, Cominelli F
    Role of TL1A in perianal fistulising Crohn's disease: a new therapeutic target?
    Gut. 2026 Jan 23:gutjnl-2025-337684. doi: 10.1136/gutjnl-2025-337684.
    PubMed        

  9. CONSTANTINE-COOKE N, Gros B, Plevris N, Williams LJ, et al
    Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.
    Gut. 2026 Jan 19:gutjnl-2025-337846. doi: 10.1136/gutjnl-2025-337846.
    PubMed         Abstract available


    Inflamm Bowel Dis

  10. YOUN J, Nielsen J, Sorensen E, Wod M, et al
    The Prevalence of Chronic Opioid Use in Patients With Inflammatory Bowel Disease: A Nationwide Danish Register-Based Study Over a 25-Year Period of Time.
    Inflamm Bowel Dis. 2026 Jan 20:izaf308. doi: 10.1093.
    PubMed         Abstract available

  11. KIM GH, Kim J, Ahn JY, Park SH, et al
    Endoscopic and pathologic findings of esophagogastroduodenal involvement in Crohn disease in Korea: a prospective single-center cohort study.
    Inflamm Bowel Dis. 2026 Jan 20:izaf320. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  12. AILAWADI S, Parikh T, Harper E, Perez J, et al
    Increased Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease: A Retrospective Multicenter Study.
    J Clin Gastroenterol. 2026 Jan 19. doi: 10.1097/MCG.0000000000002327.
    PubMed         Abstract available

  13. BALI AS, El Sheikh WG, Ouni A, Kwon J, et al
    Radiographically-Measured Sarcopenia Predicts Hospitalization in Patients With Crohn's Disease.
    J Clin Gastroenterol. 2026 Jan 20. doi: 10.1097/MCG.0000000000002317.
    PubMed         Abstract available

  14. AILAWADI S, Sethi S, Mahmood A, Harper E, et al
    Extraintestinal Cutaneous Manifestations in Inflammatory Bowel Disease Among Non-White Patients: A Retrospective Multicenter Study.
    J Clin Gastroenterol. 2026 Jan 20. doi: 10.1097/MCG.0000000000002325.
    PubMed         Abstract available

  15. SUN H, Chen H, Zhou Z, Zhou J, et al
    The Impact of Sarcopenia on the Efficacy of Ustekinumab in Crohn's Disease.
    J Clin Gastroenterol. 2026 Jan 26. doi: 10.1097/MCG.0000000000002331.
    PubMed         Abstract available

  16. BERNSTEIN CN, Nugent Z, Panaccione R, Marshall DA, et al
    Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.
    J Clin Gastroenterol. 2026 Jan 23. doi: 10.1097/MCG.0000000000002329.
    PubMed         Abstract available


    J Crohns Colitis

  17. HAWTHORNE AB, Christiansen P, Arnott I, Cummings F, et al
    Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD services.
    J Crohns Colitis. 2026 Jan 23:jjag005. doi: 10.1093.
    PubMed         Abstract available

  18. MAGRO F, Rogler G, Feagan BG, Peyrin-Biroulet L, et al
    Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib.
    J Crohns Colitis. 2026 Jan 22:jjaf228. doi: 10.1093.
    PubMed         Abstract available

  19. ORLEMANN T, Zimmermann D, Hubner H, Atreya R, et al
    Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease.
    J Crohns Colitis. 2026;20:jjaf232.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  20. ARMET AM, Wine E
    Cyclic exclusive enteral nutrition: a novel approach to maintaining remission in paediatric Crohn's disease.
    Lancet Gastroenterol Hepatol. 2026 Jan 19:S2468-1253(25)00325.
    PubMed        

  21. PIGNEUR B, Martinez-Vinson C, Bourmaud A, Dabadie A, et al
    Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2026 Jan 19:S2468-1253(25)00262.
    PubMed         Abstract available


    PLoS One

  22. SHENG Z, Zhao L, Fu Y, Liu X, et al
    Identification of hypoxia- and mitophagy-related diagnostic biomarkers for ulcerative colitis based on bioinformatic analysis and machine learning.
    PLoS One. 2026;21:e0339296.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.